131 related articles for article (PubMed ID: 11408530)
1. D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant.
Zhou D; Lauderback CM; Yu T; Brown SA; Butterfield DA; Thompson JS
J Pharmacol Exp Ther; 2001 Jul; 298(1):103-9. PubMed ID: 11408530
[TBL] [Abstract][Full Text] [Related]
2. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of xanthic acid are novel antioxidants: application to synaptosomes.
Lauderback CM; Drake J; Zhou D; Hackett JM; Castegna A; Kanski J; Tsoras M; Varadarajan S; Butterfield DA
Free Radic Res; 2003 Apr; 37(4):355-65. PubMed ID: 12747729
[TBL] [Abstract][Full Text] [Related]
4. In vivo protection of synaptosomes from oxidative stress mediated by Fe2+/H2O2 or 2,2-azobis-(2-amidinopropane) dihydrochloride by the glutathione mimetic tricyclodecan-9-yl-xanthogenate.
Joshi G; Sultana R; Perluigi M; Butterfield DA
Free Radic Biol Med; 2005 Apr; 38(8):1023-31. PubMed ID: 15780760
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the xanthate, D609, on Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress in primary neuronal cells.
Sultana R; Newman S; Mohmmad-Abdul H; Keller JN; Butterfield DA
Free Radic Res; 2004 May; 38(5):449-58. PubMed ID: 15293552
[TBL] [Abstract][Full Text] [Related]
6. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
Girón-Calle J; Srivatsa K; Forman HJ
J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
[TBL] [Abstract][Full Text] [Related]
7. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease.
Mohmmad Abdul H; Butterfield DA
Biochim Biophys Acta; 2005 Jun; 1741(1-2):140-8. PubMed ID: 15955457
[TBL] [Abstract][Full Text] [Related]
8. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
Kiss Z; Tomono M
Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
[TBL] [Abstract][Full Text] [Related]
9. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders.
Ansari MA; Joshi G; Huang Q; Opii WO; Abdul HM; Sultana R; Butterfield DA
Free Radic Biol Med; 2006 Dec; 41(11):1694-703. PubMed ID: 17145558
[TBL] [Abstract][Full Text] [Related]
10. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
Adibhatla RM; Hatcher JF; Gusain A
Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
[TBL] [Abstract][Full Text] [Related]
11. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
Kiss Z; Crilly KS; Chung T
Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
[TBL] [Abstract][Full Text] [Related]
13. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications.
Bhat AH; Dar KB; Khan A; Alshahrani S; Alshehri SM; Ghoneim MM; Alam P; Shakeel F
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328726
[TBL] [Abstract][Full Text] [Related]
14. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
Larsen EC; Hatcher JF; Adibhatla RM
Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
[TBL] [Abstract][Full Text] [Related]
15. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
Amtmann E
Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
[TBL] [Abstract][Full Text] [Related]
16. D609 inhibits the proliferation of neural progenitor cells.
Kalluri HS; Dempsey RJ
Neuroreport; 2010 Jul; 21(10):700-3. PubMed ID: 20568314
[TBL] [Abstract][Full Text] [Related]
17. Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609).
Tschaikowsky K; Meisner M; Schönhuber F; Rügheimer E
Br J Pharmacol; 1994 Nov; 113(3):664-8. PubMed ID: 7532078
[TBL] [Abstract][Full Text] [Related]
18. Leaf extract of Moringa oleifera prevents ionizing radiation-induced oxidative stress in mice.
Sinha M; Das DK; Bhattacharjee S; Majumdar S; Dey S
J Med Food; 2011 Oct; 14(10):1167-72. PubMed ID: 21861723
[TBL] [Abstract][Full Text] [Related]
19. The antiviral xanthate compound D609 inhibits herpes simplex virus type 1 replication and protein phosphorylation.
Walro DG; Rosenthal KS
Antiviral Res; 1997 Sep; 36(1):63-72. PubMed ID: 9330762
[TBL] [Abstract][Full Text] [Related]
20. Prodrug modification increases potassium tricyclo[5.2.1.0(2,6)]-decan-8-yl dithiocarbonate (D609) chemical stability and cytotoxicity against U937 leukemia cells.
Bai A; Meier GP; Wang Y; Luberto C; Hannun YA; Zhou D
J Pharmacol Exp Ther; 2004 Jun; 309(3):1051-9. PubMed ID: 14960662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
